Patients’ characteristics summary
| Characteristics | Patients (n = 114) | ||
|---|---|---|---|
| Age | 63 | (29,83) | |
| Sex | Male | 81 | 71.1 |
| Female | 33 | 28.9 | |
| KRAS mutation | Mutated | 35 | 30.7 |
| Wild type | 79 | 69.3 | |
| BRAF mutation | Mutated | 3 | 2.6 |
| Wild type | 111 | 97.4 | |
| Tumor side | Left | 89 | 78.1 |
| Right | 25 | 21.9 | |
| Chemotherapy | Neoadjuvant | 78 | 68.4 |
| adjuvant | 30 | 26.3 | |
| None | 6 | 5.2 | |
| Type of Chemotherapy | FOLFOX | 47 | 60 |
| FOLFOX anti VEGF | 18 | 23 | |
| FOLFOX anti EGFR | 11 | 14 | |
| Other | 2 | 3 | |
| Other | 45 | 57.7 | |